H. Oonishi, L. L. Hench, J. Wilson, F. Sugihara, E. Tsuji, M. Matsuwura, S. Kin, T. Yamamoto and S. Mizokawa, “Quantitative Comparison of Bone Growth Behaviour in Granules in Bioglass®, A-W GlassCeramic, and Hydroxyapatite,” Journal of Biomedical Materials Research, Vol. 51, No. 1, 2000, pp. 37-46. doi:10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T

has been cited by the following article:

• TITLE: Chronology of Bioactive Glass Development and Clinical Applications

  AUTHORS: Larry L. Hench

  KEYWORDS: Bioactive Glass; 45S5 Bioglass; Hydroxyl-Carbonate Apatite (HCA); Bone-Bonding; Osteogenesis; Regeneration; Genes, Dental; ENT; Maxillo-Facial; Orthopedics; Clinical; Osteostimulation

  JOURNAL NAME: New Journal of Glass and Ceramics, Vol.3 No.2, April 30, 2013

  ABSTRACT: The key research and development steps for bioactive glass (45S5 Bioglass) are documented from the date of discovery in 1969 through FDA approvals of the first dental, ENT, maxillo-facial and orthopedic clinical products. Understanding the mechanisms and quantifying the rapid surface reactions to form a bone-bonding hydroxyl-carbonate apatite (HCA) layer on the bioactive glass in contact with living bone was a vital part of the early development of this class of biomaterials. A key later discovery was enhanced osteogenesis and in situ bone regeneration by controlled release of ionic dissolution products from the bioactive glass particulates that leads to up-regulation and activation of seven families of genes, a process called osteostimulation.